Meier R, Lochs H
Medizinische Universitätsklinik, Abteilung für Gastroenterologie, Hepatologie und Ernährung, Kantonsspital, Liestal, Switzerland.
Ther Umsch. 2007 Mar;64(3):161-9. doi: 10.1024/0040-5930.64.3.161.
Nowadays, the regular consumption of pre- and probiotics is recommended to provide various positive health benefits. The in vitro and in vivo demonstrated actions on the intestinal microflora, the mucosal barrier and the immunological system are very interesting to propose beneficial health effects, but the scientific proof in humans is not demonstrated yet. Pre- and probiotics are very active in the intestinal tract (mainly in the colon) by maintaining a healthy gut microflora and influencing metabolic, trophic and protective mechanism. Prebiotics stimulates the growth of apathogen bacteria and increase the short chain fatty acid concentration by fermentation. Short chain fatty acids are necessary substrates for a healthy gut. Probiotics inhibit the growth of pathogen bacteria, reduce the translocation of bacteria and toxins and modulate the intestinal immune system. For some specific clinical diseases (ulcerative colitis, pouchitis, diarrhoea) a therapeutic and prophylactic effect with pre- and probiotics was shown. In the near future more indications for pre- and probiotics (used as a single strain or as in a combination) will be added. Promising results are already shown in irritable bowel syndrome, prevention of antibiotic induced diarrhoea, in surgical and in intensive care patients. Future studies should focus to determine the characteristics of a healthy gut and the evaluation of specific health benefits by well-designed, controlled human studies of adequate duration.
如今,建议经常食用益生元和益生菌以带来各种积极的健康益处。体外和体内实验表明,它们对肠道微生物群、黏膜屏障和免疫系统有作用,这对于提出有益健康的效果很有意思,但在人体中的科学证据尚未得到证实。益生元和益生菌在肠道(主要是结肠)中非常活跃,可维持健康的肠道微生物群,并影响代谢、营养和保护机制。益生元刺激有益菌的生长,并通过发酵增加短链脂肪酸的浓度。短链脂肪酸是健康肠道所需的底物。益生菌抑制病原菌的生长,减少细菌和毒素的移位,并调节肠道免疫系统。对于某些特定的临床疾病(溃疡性结肠炎、袋炎、腹泻),益生元和益生菌已显示出治疗和预防作用。在不久的将来,将增加更多益生元和益生菌(作为单一菌株或组合使用)的适应症。在肠易激综合征、预防抗生素相关性腹泻、外科手术患者和重症监护患者中已显示出有前景的结果。未来的研究应着重确定健康肠道的特征,并通过精心设计、有对照且持续时间足够的人体研究来评估特定的健康益处。